ERBB2 and breast carcinoma: MDA-MB-231 was used as the cell model for HER2-negative breast cancer, SK-BR-3 for HER2-positive anti-HER2 sensitive breast cancer, and HCC1569 cells for anti-HER2 resistant with PTEN-loss (Fig. 1a).